Literature DB >> 8999967

Translational regulation of lipoprotein lipase by epinephrine involves a trans-acting binding protein interacting with the 3' untranslated region.

G Ranganathan1, D Vu, P A Kern.   

Abstract

To better characterize the translational regulation of lipoprotein lipase (LPL) by epinephrine, cytoplasmic extracts were prepared from 3T3-L1 adipocytes, 3T3-F442A adipocytes, and other nonadipocyte cell lines (C2 cells, 3T3 fibroblasts, and Chinese hamster ovary cells). After treatment with epinephrine, cell extracts from the adipocytes inhibited LPL translation in an in vitro translation assay, whereas extracts from the C2 cells and 3T3 fibroblasts did not affect LPL translation. To identify the region on the LPL mRNA that controlled translation, in vitro translation was carried out using constructs containing different LPL sequences. Specific deletion of the first 50 (1601-1650) nucleotides of the 3' untranslated region (UTR) resulted in a loss of translation inhibition. The addition of LPL 3' UTR to a heterologous reporter gene construct resulted in an inhibition of translation. Inhibition of the reporter LPL 3' UTR translation was demonstrated by the addition of epinephrine-treated cell extracts to an in vitro translation assay, as well as by transfection of this construct into 3T3-F442A cells, followed by treatment of the cells with epinephrine. Competition for a trans-acting binding protein was demonstrated by the addition of sense mRNA strands corresponding to the proximal 135 nucleotides of the 3' UTR of LPL. To identify a RNA-binding protein, adipocyte extracts were incubated with 32P-labeled RNA sequences followed by RNase treatment. The epinephrine-treated cell extract protected a fragment of RNA when the RNA included sequences on the proximal 3' UTR of LPL. Cross-linking of this protected fragment and analysis by SDS-polyacrylamide gel electrophoresis revealed a protein that migrated at about 30 kDa. Thus, the addition of epinephrine to 3T3 adipocytes results in an inhibition of translation through the production of a RNA-binding protein that binds to a region on the proximal 3' UTR of the LPL mRNA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8999967     DOI: 10.1074/jbc.272.4.2515

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  A GG nucleotide sequence of the 3' untranslated region of amyloid precursor protein mRNA plays a key role in the regulation of translation and the binding of proteins.

Authors:  E G Mbella; S Bertrand; G Huez; J N Octave
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

2.  The 3'-untranslated region of human interleukin-8 mRNA suppresses IL-8 gene expression.

Authors:  Y Yu; K Chadee
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

3.  Masking, unmasking, and regulated polyadenylation cooperate in the translational control of a dormant mRNA in mouse oocytes.

Authors:  A Stutz; B Conne; J Huarte; P Gubler; V Völkel; P Flandin; J D Vassalli
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

4.  Effects of caffeine on lipoprotein lipase gene expression during the adipocyte differentiation process.

Authors:  C Couturier; B Janvier; D Girlich; G Béréziat; M Andréani-Mangeney
Journal:  Lipids       Date:  1998-05       Impact factor: 1.880

5.  The lipoprotein lipase (LPL) S447X gain of function variant involves increased mRNA translation.

Authors:  Gouri Ranganathan; Resat Unal; Irina D Pokrovskaya; Preeti Tripathi; Jerome I Rotter; Mark O Goodarzi; Philip A Kern
Journal:  Atherosclerosis       Date:  2011-12-27       Impact factor: 5.162

6.  Translational regulation of lipoprotein lipase in adipocytes: depletion of cellular protein kinase Calpha activates binding of the C subunit of protein kinase A to the 3'-untranslated region of the lipoprotein lipase mRNA.

Authors:  Resat Unal; Irina Pokrovskaya; Preeti Tripathi; Brett P Monia; Philip A Kern; Gouri Ranganathan
Journal:  Biochem J       Date:  2008-07-15       Impact factor: 3.857

7.  Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site.

Authors:  Kris Richardson; Jennifer A Nettleton; Noemi Rotllan; Toshiko Tanaka; Caren E Smith; Chao-Qiang Lai; Laurence D Parnell; Yu-Chi Lee; Jari Lahti; Rozenn N Lemaitre; Ani Manichaikul; Margaux Keller; Vera Mikkilä; Julius Ngwa; Frank J A van Rooij; Christie M Ballentyne; Ingrid B Borecki; L Adrienne Cupples; Melissa Garcia; Albert Hofman; Luigi Ferrucci; Dariush Mozaffarian; Mia-Maria Perälä; Olli Raitakari; Russell P Tracy; Donna K Arnett; Stefania Bandinelli; Eric Boerwinkle; Johan G Eriksson; Oscar H Franco; Mika Kähönen; Michael Nalls; David S Siscovick; Denise K Houston; Bruce M Psaty; Jorma Viikari; Jacqueline C M Witteman; Mark O Goodarzi; Terho Lehtimäki; Yongmei Liu; M Carola Zillikens; Yii-Der I Chen; André G Uitterlinden; Jerome I Rotter; Carlos Fernandez-Hernando; Jose M Ordovas
Journal:  Am J Hum Genet       Date:  2012-12-13       Impact factor: 11.025

8.  Functional significance of lipoprotein lipase HindIII polymorphism associated with the risk of coronary artery disease.

Authors:  Qi Chen; Hamid Razzaghi; F Yesim Demirci; M Ilyas Kamboh
Journal:  Atherosclerosis       Date:  2008-02-01       Impact factor: 5.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.